The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, is issuing a Request for Information (RFI) for the Rapid Access to Products in Development (RAPID) program. This RFI seeks information on capabilities related to the storage, inventory management, distribution, retrieval, and disposal of medical countermeasures (MCMs), as well as stability testing and quality assurance practices in compliance with current Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP). The RAPID program is crucial for ensuring that Combatant Commands and stakeholders have timely access to effective prophylactics and therapeutics in response to chemical and biological threats. Responses to this RFI are due by October 31, 2025, and should be submitted via email to David Bailey at the provided contact information.